Company Search:
Advanced Search
Sponsored Links
Ypsomed Holding AG Company Snapshot
Ypsomed Holding AG operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ypsomed Holding AG with three other medical equipment manufacturers in Europe: Orthofix International NV of the Netherlands (2017 sales of 380.84 million Euro [US$471.33 million] of which 43% was BioStim), Consort Medical Plc of the United Kingdom (£294.00 million [US$417.61 million] of which 59% was Aesica), and Ambu A/S which is based in Denmark (2.36 billion Danish Kroner [US$391.26 million] of which 39% was Anaesthesia).

Sales Analysis. During the year ended March of 2017, sales at Ypsomed Holding AG were 389.56 million Swiss Francs (US$402.02 million). This is an increase of 15.6% versus 2016, when the company's sales were 336.92 million Swiss Francs. This was the fourth straight year of sales growth at Ypsomed Holding AG. Sales of Delivery Devices saw an increase that was more than double the company's growth rate: sales were up 45.6% in 2017, from 168.89 million Swiss Francs to 245.86 million Swiss Francs. Not all segments of Ypsomed Holding AG experienced an increase in sales in 2017: sales of Diabetes Direct Business fell 15.7% to 127.93 million Swiss Francs. Ypsomed Holding AG also experienced decreases in sales in Other Products (down 2.8% to 15.77 million Swiss Francs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ypsomed Holding AG
  Stock Performance Chart for Ypsomed Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 144.40
(Figures in Swiss Francs)
1 Week -0.5%   13 Weeks -0.6%  
4 Weeks -17.2%   52 Weeks -24.2%  
Ypsomed Holding AG Key Data:
  Ticker: YPSN Country: Switzerland
  Exchanges: ZHR Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2017 Sales 389,555,000
(Year Ending Jan 2018).
Employees: 1,314
  Currency: Swiss Francs Market Cap: 1,822,321,213
  Fiscal Yr Ends: March Shares Outstanding: 12,619,953
  Share Type: Inhaberaktie Closely Held Shares: 9,151,174
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.